Chemcrux Enterp.

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: INE298W01016
  • NSEID:
  • BSEID: 540395
INR
111.60
-1.25 (-1.11%)
BSENSE

Feb 06

BSE+NSE Vol: 8.61 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

8.61 k (-10.74%) Volume

Shareholding (Dec 2025)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

72.92%

how big is Chemcrux Enterp.?

06-Jun-2025

As of Jun 06, Chemcrux Enterprises Ltd has a market capitalization of 204.00 Cr, with recent net sales of 70.01 Cr and a net profit of 3.92 Cr over the last four quarters. Shareholder's funds are 72.26 Cr, and total assets amount to 109.87 Cr as of the latest annual period ending in Mar'24.

Market Cap: As of Jun 06, Chemcrux Enterprises Ltd has a market capitalization of 204.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest 4 quarters, the sum of Net Sales is 70.01 Cr and the sum of Net Profit is 3.92 Cr. This data is Consolidated.<BR><BR>Balance Sheet Snapshot: This is Consolidated data for the latest annual period ending in Mar'24. Shareholder's Funds are reported at 72.26 Cr, and Total Assets amount to 109.87 Cr.

View full answer

Who are in the management team of Chemcrux Enterp.?

06-Jun-2025

As of March 2023, the management team of Chemcrux Enterprises includes Chairman Girish Shah, Managing Director Sanjaybhai Marathe, Non-Executive Director Neela Marathe, and several Independent Directors: Bhanubhai Patel, Shaileshkumar Patel, and Mukund P Bakshi, along with Additional Director Sidhdhi Shah. The team features a mix of executive and independent members, guiding the company's governance and strategy.

As of March 2023, the management team of Chemcrux Enterprises includes the following members:<BR><BR>1. **Girish Shah** - Chairman & Executive Director, with a remuneration of Rs. 1.18 crore.<BR>2. **Sanjaybhai Marathe** - Executive Director / Managing Director / Promoter, also with a remuneration of Rs. 1.18 crore.<BR>3. **Neela Marathe** - Non-Executive Director, with a remuneration of Rs. 45,000.<BR>4. **Bhanubhai Patel** - Independent Director, with a remuneration of Rs. 35,000.<BR>5. **Shaileshkumar Patel** - Independent Director, with a remuneration of Rs. 55,000.<BR>6. **Mukund P Bakshi** - Independent Director, with a remuneration of Rs. 50,000.<BR>7. **Sidhdhi Shah** - Additional Director, with no remuneration.<BR><BR>This team comprises a mix of executive, non-executive, and independent directors, contributing to the governance and strategic direction of the company.

View full answer

What is the bonus history of the Chemcrux Enterp.?

06-Jun-2025

Chemcrux Enterprises Ltd issued a 2:1 bonus on September 6, 2021, with a record date of September 7, 2021, granting shareholders two additional shares for every one share held.

Chemcrux Enterprises Ltd has a bonus history that includes a 2:1 bonus issue announced with an ex-date of September 6, 2021. The record date for this bonus was September 7, 2021. This means that shareholders received two additional shares for every one share they held as of the record date. If you have any more questions about the company or its financial activities, feel free to ask!

View full answer

Has Chemcrux Enterp. declared dividend?

06-Jun-2025

Chemcrux Enterprises Ltd has declared a 10% dividend, amounting to 1 per share, with an ex-date of September 6, 2024. While the company shows significant negative total returns in the short to medium term, it has delivered positive returns over the longer term.

Chemcrux Enterprises Ltd has declared a 10% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 10%<BR>- Amount per share: 1 per share<BR>- Ex-date: 06 Sep 2024<BR><BR>Dividend Yield: 0.73%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -26.3%, the dividend return was 0%, resulting in a total return of -26.3%.<BR><BR>Over the past year, the price return was -40.01%, the dividend return was 0.43%, leading to a total return of -39.58%.<BR><BR>In the 2-year period, the price return was -58.28%, the dividend return was 0.93%, which resulted in a total return of -57.35%.<BR><BR>For the 3-year period, the price return was -32.56%, the dividend return was 2.07%, culminating in a total return of -30.49%.<BR><BR>In the last 4 years, the price return was 37.18%, the dividend return was 7.64%, resulting in a total return of 44.82%.<BR><BR>Over the past 5 years, the price return was 350.98%, the dividend return was 17.00%, leading to a total return of 367.98%.<BR><BR>Overall, while Chemcrux Enterprises Ltd has declared a dividend, the total returns over various periods show significant fluctuations, with negative returns in the short to medium term but positive returns over the longer term.

View full answer

Who are the peers of the Chemcrux Enterp.?

03-Jun-2025

Chemcrux Enterp.'s peers include Pidilite Inds., SRF, Gujarat Fluoroch, Deepak Nitrite, Himadri Special, Polson, Deepak, Resonance Speci., and Deep Polymers. Chemcrux has average management risk, below-average growth, and the lowest 1-year return among its peers at -37.35%.

Peers: The peers of Chemcrux Enterp. are Pidilite Inds., SRF, Gujarat Fluoroch, Deepak Nitrite, Himadri Special, Polson, Deepak, Resonance Speci., Deep Polymers.<BR><BR>Quality Snapshot: Excellent management risk is observed at Deepak, while Good management risk is found at Pidilite Inds. and SRF. Average management risk is present at Gujarat Fluoroch, Himadri Special, Chemcrux Enterp., and Resonance Speci., while Below Average management risk is noted at Polson and Deep Polymers. Growth is Excellent at Deepak, Good at Himadri Special, Average at Pidilite Inds. and SRF, while Below Average growth is seen at Gujarat Fluoroch, Deepak Nitrite, Chemcrux Enterp., and Resonance Speci., and the rest. Capital Structure is Excellent at Pidilite Inds., SRF, and Deepak, Good at Himadri Special, Chemcrux Enterp., and Deep Polymers, while Average is noted at Polson and Below Average at Gujarat Fluoroch.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Deepak at 62.79%, while Chemcrux Enterp. has the lowest at -37.35%. Chemcrux's return is significantly lower than all peers. Additionally, the six-month return is negative for Deepak Nitrite, Chemcrux Enterp., Gujarat Fluoroch, and Deep Polymers.

View full answer

What is the technical trend for Chemcrux Enterp.?

09-Jun-2025

As of June 4, 2025, Chemcrux Enterprises has shifted to a bearish trend with moderate strength, indicated by bearish daily moving averages, a declining weekly RSI, a bearish monthly MACD, and a 40.43% decline over the past year.

As of 4 June 2025, the technical trend for Chemcrux Enterp. has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. Key indicators driving this include the daily moving averages indicating bearish momentum, the weekly RSI showing bearish conditions, and the monthly MACD reflecting a bearish trend. Additionally, the Bollinger Bands on both weekly and monthly time frames are mildly bearish, reinforcing the overall bearish outlook. The stock's performance over the past year shows a significant decline of 40.43%, further supporting the bearish sentiment.

View full answer

What does Chemcrux Enterp. do?

17-Jul-2025

Chemcrux Enterprises Ltd is a micro-cap company in the specialty chemicals industry, reporting net sales of ₹157 Cr and a net profit of ₹2 Cr for the quarter ending March 2025. The company has a market cap of ₹193 Cr and key metrics include a P/E of 49.00 and a dividend yield of 0.77%.

Overview:<BR>Chemcrux Enterprises Ltd operates in the specialty chemicals industry and is categorized as a micro-cap company.<BR><BR>History:<BR>The company was incorporated on April 15, 1996, and took over the business of M/s. Chemcrux, a partnership firm established in 1981, in December 1999. The latest quarterly results reported net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 157 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 2 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: INR 193 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 49.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 0.77% <BR>Debt Equity: 0.29 <BR>Return on Equity: 5.25% <BR>Price to Book: 2.57 <BR><BR>Contact Details:<BR>Address: 330 TRIVIA Complex, Natubhai Circle Racecourse Vadodara Gujarat : 390007 <BR>Tel: 91-265-2344803/2358903 <BR>Email: girishshah@chemcrux.com <BR>Website: http://www.chemcrux.com

View full answer

Who are the top shareholders of the Chemcrux Enterp.?

17-Jul-2025

The top shareholder of Chemcrux Enterprises is Sanjay Marathe, holding 36.46%. The highest public shareholder is Namita Bhandare at 1.49%, while individual investors collectively own 25.88% of the shares.

The top shareholders of Chemcrux Enterprises include the promoters, with Sanjay Marathe holding the highest stake at 36.46%. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors (FIIs) holding shares. The highest public shareholder is Namita Bhandare, who owns 1.49% of the company. Additionally, individual investors collectively hold 25.88% of the shares.

View full answer

How has been the historical performance of Chemcrux Enterp.?

06-Nov-2025

Chemcrux Enterp. has shown a declining trend in financial performance over the past three years, with net sales and profits significantly decreasing while total assets and debt increased. The company has struggled with profitability and cash flow, resulting in a net cash outflow in the latest year.

Answer:<BR>The historical performance of Chemcrux Enterp. shows a declining trend in key financial metrics over the past three years.<BR><BR>Breakdown:<BR>Chemcrux Enterp. has experienced a decrease in net sales, dropping from 95.15 Cr in Mar'23 to 70.01 Cr in Mar'25. Total operating income followed a similar trend, declining from 95.15 Cr in Mar'23 to 70.01 Cr in Mar'25. The total expenditure, excluding depreciation, also decreased from 73.70 Cr in Mar'23 to 60.78 Cr in Mar'25. Operating profit (PBDIT) has seen a significant decline from 22.50 Cr in Mar'23 to 10.72 Cr in Mar'25, while profit before tax fell from 19.65 Cr to 5.77 Cr in the same period. Consequently, profit after tax decreased from 14.36 Cr in Mar'23 to 3.91 Cr in Mar'25, reflecting a drop in earnings per share from 9.7 to 2.64. The company's total assets increased from 93.22 Cr in Mar'23 to 127.05 Cr in Mar'25, alongside a rise in total debt from 13.42 Cr to 41.53 Cr. Cash flow from operating activities also declined from 14.00 Cr in Mar'23 to 7.00 Cr in Mar'25, contributing to a net cash outflow of 4.00 Cr in the latest year. Overall, Chemcrux Enterp. has faced challenges in maintaining profitability and managing its financial health over the observed period.

View full answer

Is Chemcrux Enterp. overvalued or undervalued?

21-Nov-2025

As of November 20, 2025, Chemcrux Enterprises is fairly valued with a PE ratio of 92.25, but has underperformed the Sensex with a year-to-date return of -32.58%, raising concerns about its growth prospects in the specialty chemicals sector.

As of 20 November 2025, the valuation grade for Chemcrux Enterprises has moved from expensive to fair. The company is currently fairly valued, with a PE ratio of 92.25, an EV to EBITDA of 22.72, and a Price to Book Value of 2.26. Compared to its peers, Chemcrux's valuation metrics are relatively high; for instance, Solar Industries has a PE of 95.5 and an EV to EBITDA of 58.77, while Godrej Industries is more attractive with a PE of 36.6 and an EV to EBITDA of 40.38.<BR><BR>Despite the fair valuation, Chemcrux has underperformed significantly compared to the Sensex, with a year-to-date return of -32.58% against the Sensex's 9.59%. This stark contrast in performance may indicate potential concerns about the company's growth prospects or market positioning within the specialty chemicals sector.

View full answer

When is the next results date for Chemcrux Enterprises Ltd?

30-Jan-2026

The next results date for Chemcrux Enterprises Ltd is February 5, 2026.

The next results date for Chemcrux Enterprises Ltd is scheduled for February 5, 2026.

View full answer

Are Chemcrux Enterprises Ltd latest results good or bad?

06-Feb-2026

Chemcrux Enterprises Ltd's latest quarterly results show significant profit and sales growth, but a concerning 49.33% decline in net profit over the nine-month period and a long-term trend of declining sales and profitability raise doubts about the sustainability of this improvement. Overall, the financial health and long-term outlook remain troubling despite recent gains.

Chemcrux Enterprises Ltd's latest results present a mixed picture. On one hand, the company reported a significant increase in net profit for Q3 FY26, reaching ₹1.58 crore, which is a remarkable 652.38% increase quarter-on-quarter (QoQ) and a 19.70% increase year-on-year (YoY). Additionally, net sales for the same quarter were ₹22.11 crore, reflecting a 24.56% QoQ and 13.85% YoY growth, marking the highest revenue in at least eight quarters.<BR><BR>The operating margin also improved to 15.97%, the best performance in two years, indicating some operational momentum. However, despite these positive quarterly results, the nine-month profit for FY26 shows a concerning decline of 49.33% YoY, with total net profit for the period at ₹1.88 crore, down from ₹3.71 crore in the previous year. This raises questions about the sustainability of the recent uptick in performance.<BR><BR>Furthermore, the company's long-term outlook is troubling, with a five-year decline in net sales at an annual rate of 13.89% and a significant drop in profitability over the past two years. The stock has also underperformed significantly, down 28.87% over the past year and 66.31% over three years.<BR><BR>In summary, while the latest quarterly results show improvement, the overall financial health and long-term trajectory of Chemcrux Enterprises Ltd remain concerning, suggesting that the recent gains may not be indicative of a sustainable recovery.

View full answer

Should I buy, sell or hold Chemcrux Enterprises Ltd?

06-Feb-2026

Why is Chemcrux Enterprises Ltd falling/rising?

08-Feb-2026

As of 08-Feb, Chemcrux Enterprises Ltd's stock is declining by 1.11% after a trend reversal, despite initial gains and increased investor participation. The long-term outlook is poor due to declining sales and profits, leading to consistent underperformance against benchmarks.

As of 08-Feb, Chemcrux Enterprises Ltd's stock price is currently falling, with a change of -1.25, representing a decline of 1.11%. This decline follows a trend reversal after four consecutive days of gains. Although the stock opened with a gain of 3.68% today and reached an intraday high of Rs 118.8, it also experienced significant volatility, trading in a wide range of Rs 12.58, with a day's low of Rs 106.22, which reflects a decrease of 5.88%.<BR><BR>The stock's performance today has underperformed its sector by 0.31%. Furthermore, despite rising investor participation indicated by a substantial increase in delivery volume, the overall long-term outlook remains poor. Over the past five years, the company has seen a decline in net sales at an annual rate of -9.98% and a significant drop in operating profit by -38.75%. The stock has consistently underperformed against benchmarks, generating a return of -29.43% over the last year while profits have fallen by -33.7%. This consistent underperformance, combined with the company's low return on capital employed (ROCE) and expensive valuation metrics, contributes to the current downward pressure on the stock price.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

Poor long term growth as Net Sales has grown by an annual rate of -13.89% and Operating profit at -42.95% over the last 5 years

 
2

Flat results in Dec 25

3

With ROCE of 4.2, it has a Expensive valuation with a 2 Enterprise value to Capital Employed

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

INR 163 Cr (Micro Cap)

stock-summary
P/E

79.00

stock-summary
Industry P/E

39

stock-summary
Dividend Yield

0.89%

stock-summary
Debt Equity

0.24

stock-summary
Return on Equity

2.45%

stock-summary
Price to Book

2.24

Revenue and Profits:
Net Sales:
22 Cr
(Quarterly Results - Dec 2025)
Net Profit:
2 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.89%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.03%
0%
-8.03%
6 Months
-7.81%
0.85%
-6.96%
1 Year
-29.43%
0.70%
-28.73%
2 Years
-60.55%
0.67%
-59.88%
3 Years
-66.59%
1.31%
-65.28%
4 Years
-32.03%
4.07%
-27.96%
5 Years
47.81%
11.72%
59.53%

Latest dividend: 1 per share ex-dividend date: Sep-17-2025

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Newspaper Publication

06-Feb-2026 | Source : BSE

Newspaper Publication of Unaudited Financial Results for the quarter and nine months ended 31st December 2025

Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2025

05-Feb-2026 | Source : BSE

Unaudited Financial Results for the quarter and nine months ended 31st December 2025

Board Meeting Outcome for Outcome Of Board Meeting Held On 05Th February 2026

05-Feb-2026 | Source : BSE

The Board of Directors considered and approved Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December 2025 for F.Y. 2025-26 as reviewed and recommended by the Audit Committee along with Limited Review Report issued by Statutory Auditors of the Company Naresh & Co. Chartered Accountants.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Chemcrux Enterprises Ltd has declared 10% dividend, ex-date: 17 Sep 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Chemcrux Enterprises Ltd has announced 2:1 bonus issue, ex-date: 06 Sep 21

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-9.98%
EBIT Growth (5y)
-38.75%
EBIT to Interest (avg)
6.29
Debt to EBITDA (avg)
1.34
Net Debt to Equity (avg)
0.24
Sales to Capital Employed (avg)
0.92
Tax Ratio
36.17%
Dividend Payout Ratio
17.54%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
19.29%
ROE (avg)
6.15%

Valuation key factors

Factor
Value
P/E Ratio
79
Industry P/E
39
Price to Book Value
2.21
EV to EBIT
40.71
EV to EBITDA
20.22
EV to Capital Employed
1.98
EV to Sales
2.54
PEG Ratio
NA
Dividend Yield
0.90%
ROCE (Latest)
4.24%
ROE (Latest)
2.45%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Sanjay Marathe (36.46%)

Highest Public shareholder

Namita Bhandare (1.49%)

Individual Investors Holdings

25.79%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 13.85% vs -10.96% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 19.70% vs -50.38% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "22.11",
          "val2": "19.42",
          "chgp": "13.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.53",
          "val2": "2.69",
          "chgp": "31.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.76",
          "val2": "0.60",
          "chgp": "26.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.58",
          "val2": "1.32",
          "chgp": "19.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.97%",
          "val2": "13.85%",
          "chgp": "2.12%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -1.75% vs -8.55% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -87.03% vs -33.05% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "34.25",
          "val2": "34.86",
          "chgp": "-1.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.42",
          "val2": "4.43",
          "chgp": "-22.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.68",
          "val2": "0.46",
          "chgp": "265.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.31",
          "val2": "2.39",
          "chgp": "-87.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.99%",
          "val2": "12.71%",
          "chgp": "-2.72%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 3.83% vs -9.43% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -49.06% vs -40.45% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "56.36",
          "val2": "54.28",
          "chgp": "3.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "6.95",
          "val2": "7.12",
          "chgp": "-2.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.44",
          "val2": "1.06",
          "chgp": "130.19%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.89",
          "val2": "3.71",
          "chgp": "-49.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.33%",
          "val2": "13.12%",
          "chgp": "-0.79%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is -10.78% vs -17.53% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -53.67% vs -41.23% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "70.01",
          "val2": "78.47",
          "chgp": "-10.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "9.23",
          "val2": "13.22",
          "chgp": "-30.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.75",
          "val2": "0.83",
          "chgp": "110.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3.91",
          "val2": "8.44",
          "chgp": "-53.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.18%",
          "val2": "16.85%",
          "chgp": "-3.67%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoYstock-summary

Dec'25
Dec'24
Change(%)
Net Sales
22.11
19.42
13.85%
Operating Profit (PBDIT) excl Other Income
3.53
2.69
31.23%
Interest
0.76
0.60
26.67%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1.58
1.32
19.70%
Operating Profit Margin (Excl OI)
15.97%
13.85%
2.12%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2025 is 13.85% vs -10.96% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is 19.70% vs -50.38% in Dec 2024

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
34.25
34.86
-1.75%
Operating Profit (PBDIT) excl Other Income
3.42
4.43
-22.80%
Interest
1.68
0.46
265.22%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.31
2.39
-87.03%
Operating Profit Margin (Excl OI)
9.99%
12.71%
-2.72%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -1.75% vs -8.55% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is -87.03% vs -33.05% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
56.36
54.28
3.83%
Operating Profit (PBDIT) excl Other Income
6.95
7.12
-2.39%
Interest
2.44
1.06
130.19%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1.89
3.71
-49.06%
Operating Profit Margin (Excl OI)
12.33%
13.12%
-0.79%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 3.83% vs -9.43% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2025 is -49.06% vs -40.45% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
70.01
78.47
-10.78%
Operating Profit (PBDIT) excl Other Income
9.23
13.22
-30.18%
Interest
1.75
0.83
110.84%
Exceptional Items
0.00
0.00
Consolidate Net Profit
3.91
8.44
-53.67%
Operating Profit Margin (Excl OI)
13.18%
16.85%
-3.67%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is -10.78% vs -17.53% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is -53.67% vs -41.23% in Mar 2024

stock-summaryCompany CV
About Chemcrux Enterprises Ltd stock-summary
stock-summary
Chemcrux Enterprises Ltd
Micro Cap
Specialty Chemicals
Chemcrux Enterprises Limited was incorporated on April 15, 1996 with Registrar of Companies, Gujarat Dadra and Nagar Haveli. The Company took over the business of M/s. Chemcrux, a Partnership Firm in December, 1999, which was formed in 1981. Chemcrux Enterprises Limited is an ISO 9001:2008 and ISO 14001:2004 certified company and is engaged in High Pressure Oxidation, Chlorosulfonation, Nitration and Amidation Chemistry for manufacturing of intermediates for bulk drugs i.e.
Company Coordinates stock-summary
Company Details
330 TRIVIA Complex, Natubhai Circle Racecourse Vadodara Gujarat : 390007
stock-summary
Tel: 91-265-2344803/2358903
stock-summary
girishshah@chemcrux.com
Registrar Details